IRIS Accounts Production v23.3.1.45 03769885 director 1.7.22 30.6.23 30.6.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh037698852022-06-30037698852023-06-30037698852022-07-012023-06-30037698852021-06-30037698852021-07-012022-06-30037698852022-06-3003769885ns10:Originalns15:EnglandWales2022-07-012023-06-3003769885ns14:PoundSterlingns10:Original2022-07-012023-06-3003769885ns10:Originalns10:Director12022-07-012023-06-3003769885ns10:Original2022-07-012023-06-3003769885ns10:Original2023-06-3003769885ns10:Originalns10:PrivateLimitedCompanyLtd2022-07-012023-06-3003769885ns10:Originalns10:SmallEntities2022-07-012023-06-3003769885ns10:Originalns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3003769885ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3003769885ns10:SmallCompaniesRegimeForAccountsns10:Original2022-07-012023-06-3003769885ns10:Originalns10:FullAccounts2022-07-012023-06-3003769885ns10:Original12022-07-012023-06-3003769885ns10:Originalns10:OrdinaryShareClass12022-07-012023-06-3003769885ns10:CompanySecretary1ns10:Original2022-07-012023-06-3003769885ns10:Originalns10:RegisteredOffice2022-07-012023-06-3003769885ns10:Original2022-06-3003769885ns10:Originalns5:CurrentFinancialInstruments2023-06-3003769885ns10:Originalns5:CurrentFinancialInstruments2022-06-3003769885ns10:Originalns5:Non-currentFinancialInstruments2023-06-3003769885ns10:Originalns5:Non-currentFinancialInstruments2022-06-3003769885ns5:ShareCapitalns10:Original2023-06-3003769885ns5:ShareCapitalns10:Original2022-06-3003769885ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-06-3003769885ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3003769885ns10:Originalns5:NetGoodwill2022-07-012023-06-3003769885ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-07-012023-06-3003769885ns10:Originalns5:PlantMachinery2022-07-012023-06-3003769885ns10:Originalns5:ComputerEquipment2022-07-012023-06-3003769885ns10:Original2021-07-012022-06-3003769885ns10:Originalns5:NetGoodwill2022-06-3003769885ns10:Originalns5:NetGoodwill2023-06-3003769885ns10:Originalns5:NetGoodwill2022-06-3003769885ns10:Originalns5:PlantMachinery2022-06-3003769885ns10:Originalns5:ComputerEquipment2022-06-3003769885ns10:Original2022-06-3003769885ns10:Originalns5:PlantMachinery2023-06-3003769885ns10:Originalns5:ComputerEquipment2023-06-3003769885ns10:Originalns5:PlantMachinery2022-06-3003769885ns10:Originalns5:ComputerEquipment2022-06-3003769885ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3003769885ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-3003769885ns10:Originalns10:OrdinaryShareClass12023-06-3003769885ns10:Original1ns10:Director12022-06-3003769885ns10:Original1ns10:Director12021-06-3003769885ns10:Original1ns10:Director12022-07-012023-06-3003769885ns10:Original1ns10:Director12021-07-012022-06-3003769885ns10:Original1ns10:Director12023-06-3003769885ns10:Original1ns10:Director12022-06-30
REGISTERED NUMBER: 03769885 (England and Wales)










Unaudited Financial Statements

for the Year Ended 30 June 2023

for

SV Pharmacies Limited

SV Pharmacies Limited (Registered number: 03769885)






Contents of the Financial Statements
for the Year Ended 30 June 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


SV Pharmacies Limited

Company Information
for the Year Ended 30 June 2023







DIRECTOR: V Patni





SECRETARY: Mrs B Patni





REGISTERED OFFICE: 7 Merlin Courtyard
Gatehouse Close
Aylesbury
HP19 8DP





REGISTERED NUMBER: 03769885 (England and Wales)





ACCOUNTANTS: Danton Partners
7 Merlin Courtyard
Gatehouse Close
Aylesbury
Buckinghamshire
HP19 8DP

SV Pharmacies Limited (Registered number: 03769885)

Statement of Financial Position
30 June 2023

30.6.23 30.6.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 1,648 1,171
1,648 1,171

CURRENT ASSETS
Stocks 6 130,000 90,000
Debtors 7 185,486 299,560
Cash at bank 76,363 46,179
391,849 435,739
CREDITORS
Amounts falling due within one year 8 67,646 125,543
NET CURRENT ASSETS 324,203 310,196
TOTAL ASSETS LESS CURRENT
LIABILITIES

325,851

311,367

CREDITORS
Amounts falling due after more than one
year

9

44,247

37,766
NET ASSETS 281,604 273,601

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 281,504 273,501
SHAREHOLDERS' FUNDS 281,604 273,601

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SV Pharmacies Limited (Registered number: 03769885)

Statement of Financial Position - continued
30 June 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 February 2024 and were signed by:





V Patni - Director


SV Pharmacies Limited (Registered number: 03769885)

Notes to the Financial Statements
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

SV Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

SV Pharmacies Limited (Registered number: 03769885)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 July 2022
and 30 June 2023 211,492
AMORTISATION
At 1 July 2022
and 30 June 2023 211,492
NET BOOK VALUE
At 30 June 2023 -
At 30 June 2022 -

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 July 2022 84,495 6,518 91,013
Additions - 1,026 1,026
At 30 June 2023 84,495 7,544 92,039
DEPRECIATION
At 1 July 2022 84,495 5,347 89,842
Charge for year - 549 549
At 30 June 2023 84,495 5,896 90,391
NET BOOK VALUE
At 30 June 2023 - 1,648 1,648
At 30 June 2022 - 1,171 1,171

6. STOCKS
30.6.23 30.6.22
£    £   
Stocks 130,000 90,000

SV Pharmacies Limited (Registered number: 03769885)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Other debtors 185,486 299,560

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Bank loans and overdrafts 12,630 6,742
Trade creditors 27,524 68,034
Taxation and social security 18,025 32,767
Other creditors 9,467 18,000
67,646 125,543

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.6.23 30.6.22
£    £   
Bank loans 44,247 37,766

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.23 30.6.22
value: £    £   
100 Ordinary £1 100 100

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2023 and 30 June 2022:

30.6.23 30.6.22
£    £   
V Patni
Balance outstanding at start of year 48,069 6,388
Amounts advanced 25,003 43,256
Amounts repaid (63,697 ) (1,575 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,375 48,069

The director owes the company £9,375 (2022 - £48,069). This is an interest bearing loan and repayable on demand. Interest of £569 has been charged on the loan.

SV Pharmacies Limited (Registered number: 03769885)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

12. RELATED PARTY DISCLOSURES

As at 30 June 2023 included within other debtors, was an amount of £4,025 (2022 - £3,076) due from 4EMK Holdings Ltd, a company controlled by V Patni. The amount loaned is interest free and there are no repayment terms in place.

As at 30 June 2023 included within other debtors, was an amount of £129,577 (2022 - £169,577) due from Horizon Property Management Ltd, a company controlled by V Patni. The amount loaned is interest free and there are no repayment terms in place.

As at 30 June 2023 included within other debtors, was an amount of £7,950 (2021 - 18,000 credit) due from 4EMK Ltd, a company controlled by V Patni. The amount loaned is interest free and there are no repayment terms in place.

13. ULTIMATE CONTROLLING PARTY

The director, V Patni, controls the company by virtue of owing all the share capital in the company.